Chad vs Guinea: HIV/AIDS deaths averted by antiretroviral therapy
Chad
5,621 deaths
in 2024
Guinea
6,473 deaths
in 2024
Chad rank
33rd
Guinea rank
31st
HIV/AIDS deaths averted by antiretroviral therapy over time
- Chad
- Guinea
How they compare
Guinea currently reports 6,473 deaths against 5,621 deaths in Chad, a difference of 852 deaths.
That makes Guinea's figure about 1.2 times Chad's.
The two have swapped places 6 times across 35 shared years of data; in 1990 it was Guinea ahead.
Chad ranks 33rd and Guinea ranks 31st of 157 countries.
Across the 4 decades both report, Chad averaged higher in 2 and Guinea in 1.
Head to head by decade
| Decade | Chad | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 925.64 deaths | 690.29 deaths | 235.35 deaths | Chad |
| 2010s | 3,844 deaths | 3,770 deaths | 74.83 deaths | Chad |
| 2020s | 5,000 deaths | 5,733 deaths | 733.59 deaths | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Chad or Guinea?
- Guinea, at 6,473 deaths against 5,621 deaths in Chad as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Chad and Guinea?
- 852 deaths, with Guinea ahead.
- How many years of comparable data are there for Chad and Guinea?
- 35 years are reported by both, from 1990 to 2024.
- How do Chad and Guinea rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Chad ranks 33rd and Guinea ranks 31st of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.